Research Triangle Institute Inc

Research Triangle Institute Inc specializes in manufacturing in vitro diagnostic (IVD) controls specifically designed for urine analyte testing. These controls are used to validate the accuracy of urine tests, ensuring reliable diagnostic results for point-of-care and laboratory settings. The primary focus is on verifying the performance of tests for various analytes in urine samples.

Research Triangle Institute Inc is based in the United States. The company’s location aligns with U.S. regulatory frameworks, which govern the development, manufacturing, and distribution of its medical devices.

The devices produced by Research Triangle Institute Inc are listed in the FDA’s Unique Device Identifier (UDI) database. This registry is a key resource for tracking and identifying medical devices authorized for use in the U.S., ensuring transparency and traceability in the supply chain.

The devices manufactured by Research Triangle Institute Inc fall under Class I classification in the U.S. regulatory system. Class I devices are generally considered low-risk, which means they are subject to minimal regulatory controls. This classification reflects the relatively straightforward design and low-risk nature of urine analyte IVD controls, which are primarily used for performance verification in diagnostic testing.